Large Italian study finds mRNA injections have significantly increased the number of cancer cases

A large Italian cohort study, published in the Journal of Experimental and Clinical Sciences, tracked cancer hospitalisation outcomes among 296,015 residents of the Pescara province over a 30-month period (June 2021–December 2023). The study compared vaccinated (83%) versus unvaccinated (17%) individuals, assessing risk across nine types of cancer.

The findings are striking: vaccination was associated with a 36% overall increased risk of hospitalisation for all cancers combined. For specific cancers, the study identified statistically significant higher risks among the vaccinated for colon-rectum cancer (+54%), breast cancer (+54%), and bladder cancer (+105%). While elevated risks were also seen for uterine, ovarian, thyroid, and haematological cancers, these were not statistically significant due to smaller sample sizes.

The authors emphasised caution, urging further research rather than sweeping conclusions. They acknowledged complexities such as the relatively short study period (30 months) compared to the long latency of some cancers, and the influence of confounding factors like diet, comorbidities, stress, and medical-seeking behaviour. Importantly, only hospitalisation data was analysed, excluding outpatient diagnoses and recurrences.

Interestingly, those who contracted COVID-19 prior to vaccination had lower hospitalisation risk than those vaccinated without prior infection, suggesting a possible immune-modulating effect—though the authors did not claim causality.

This research feeds into ongoing debate about mRNA vaccines and potential long-term risks, with other papers suggesting mechanisms such as genomic instability or immune disruption. The Italian results stand in sharp contrast to the narrative maintained by health authorities in New Zealand and elsewhere, who continue to assert vaccine safety without transparent comparative cancer data.

The report situates the study in a broader context of governmental opacity, historical judicial failures, and current legislative risks (e.g., the Gene Technology Bill). It argues that ignoring such findings could have grave public health consequences, and calls for public vigilance and political pressure.

• Study scope:

  • Conducted in Pescara province, Italy.

  • Population: 296,015 (aged 11+).

  • Timeframe: June 2021–December 2023.

  • Vaccinated: 83%; Unvaccinated: 17%.

  • Published in Journal of Experimental and Clinical Sciences.

• Main findings:

  • 36% higher overall cancer hospitalisation risk in vaccinated (p<0.001).

  • By cancer type (statistically significant):

    • Colon-rectum: +54% (p<0.046).

    • Breast: +54% (p<0.012).

    • Bladder: +105% (p<0.022).

  • Other increases (not statistically significant due to small case numbers):

    • Uterine: +93%.

    • Ovarian: +105%.

    • Thyroid: +30%.

    • Haematological: +50%.

  • No increase in lung or prostate cancers.

• Methodological notes:

  • Excluded cancer recurrences and non-hospitalised cases.

  • Cancers often develop over longer periods; risks could be underestimated.

  • Confounding variables acknowledged (diet, stress, comorbidities, etc.).

• Notable observation:

  • Prior COVID-19 infection before vaccination correlated with lower cancer hospitalisation rates than vaccination without prior infection.

• Scientific context:

  • Possible biological mechanisms: immune disruption, genetic instability linked to mRNA vaccine platforms.

  • Other peer-reviewed papers highlight concerns about genomic integration and transcriptional disruption.

• Policy implications:

  • New Zealand health authorities have not conducted comparable analyses of vaccinated vs. unvaccinated cancer outcomes.

  • Authorities continue to promote vaccine safety without robust transparency.

  • The study underscores urgent need for open debate, investigation, and accountability.

• Broader message:

  • Ignoring or suppressing such findings risks repeating past failures of justice and transparency (e.g., Air NZ Erebus disaster inquiry).

  • With legislative proposals like the Gene Technology Bill advancing, public health safeguards may be further undermined.

  • The authors and reviewers urge further research and immediate reconsideration of public health policy regarding genetic technologies.

https://expose-news.com/2025/09/06/mrna-injections-cause-cancer/